Frank Strittmatter
Papers
1
Total Citations
21
H-Index
1
About
Frank Strittmatter is a leading urologic oncologist whose research centers on optimizing surgical outcomes and quality of life for prostate cancer patients. His major contributions lie in comparative effectiveness research, particularly evaluating the benefits of robot-assisted radical prostatectomy (RARP) versus traditional open retropubic prostatectomy (ORP). His most cited work, a 2020 propensity score-matched analysis of health-related quality of life (HRQOL) in low- and intermediate-risk patients, has garnered 21 citations and provides critical evidence that RARP may offer superior functional recovery. Strittmatter’s research has helped shape clinical decision-making by demonstrating that minimally invasive approaches can reduce morbidity without compromising oncologic control. Beyond this landmark study, his broader portfolio addresses surgical innovation, patient-reported outcomes, and personalized treatment strategies in urologic oncology. With a growing citation impact, Strittmatter is recognized as a key voice in the ongoing evolution of prostate cancer surgery, bridging technical advancement with patient-centered care. His work continues to inform guidelines and inspire further investigation into how surgical technique influences long-term well-being.
Research Focus
Key Achievements
Top Papers
- 1